It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
German Federal Supreme Court (BGH) on entitlement
-
(Indirect) infringement, Amendments, Austria, Case Law, Chemical Engineering, Extent of Protection, Validity
Nebivolol, Supreme Court Austria (Oberster Gerichtshof), 19 November 2009
-
"Bolar provision" in Ukraine: fiction or reality?
-
United Kingdom: Accord Healthcare Limited v. Medac Gesellschaft Für Klinische Spezialpräparate MBH, High Court of Justice of England and Wales, Chancery Division, Patents Court, HP-2014-000011, 13 January 2016
-
A new European patent landscape (2): scope of the Unitary Patent system
-
AstraZeneca AB v. EG S.p.A, District Court of Turin (Tribunale di Torino), 14 February 2011
-
T1828/08, European Patent Office (Appeals Court), 7 December 2011
-
U.S. ITC: A Powerful Forum for Biologics Patent Owners
-
'Not all Unified Patent Courts will prosper'
-
Patent case: Verzichtsurteil, Germany